All In MedTech

FDA Clearance Tracker · P960009-S521

Activa™ Deep Brain Stimulation Therapy System, Percept™ PC BrainSense™

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Nov 13, 2025 (this decision)Source: openFDAMethods & limitations

PMA supplement

The decision

FDA number
P960009-S521
Device name
Activa™ Deep Brain Stimulation Therapy System, Percept™ PC BrainSense™
Applicant location
Minneapolis, MN
Received
Sep 3, 2025
Decided
Nov 13, 2025
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P960009

Device type

Device class
Class III

Every decision under product code MHY

FDA's approval statement

As written in FDA's record.

approval for new materials for components used in the Model 8880T2 Clinician Telemetry Module

Source documents

Other decisions for Medtronic, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.